PORTFOLIO COMPANIES

PORTFOLIO COMPANIES

GRAIL is a healthcare company located in California and its multi-cancer test for early cancer detection in individuals aged 50 or older has been granted Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).

In September 2019, Illumina, Inc. (NASDAQ: ILMN) and GRAIL announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction.

©️ 2020 All Rights Reserved 晨岭资本有限公司 版权所有 粤ICP备2020113789号